A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality | Zendy

İstemi Serin | Zendy; Nagehan Didem Sarı | Zendy; Mehmet Hilmi Doğu | Zendy; Sakine Damla Acikel | Zendy; Gulnıhal Babur | Zendy; Avni Ulusoy | Zendy; Mediha İrem Onar | Zendy; Emre Cem Gokce | Zendy; Oguz Altunok | Zendy; Feyza Yaylaci Mert | Zendy; Ayse Karakilic | Zendy; Muhammed Baltik | Zendy; Begum Gulesir | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality

Author(s) -

İstemi Serin,

Nagehan Didem Sarı,

Mehmet Hilmi Doğu,

Sakine Damla Acikel,

Gulnıhal Babur,

Avni Ulusoy,

Mediha İrem Onar,

Emre Cem Gokce,

Oguz Altunok,

Feyza Yaylaci Mert,

Ayse Karakilic,

Muhammed Baltik,

Begum Gulesir

Publication year - 2020

Publication title -

journal of infection and public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.983

H-Index - 35

eISSN - 1876-035X

pISSN - 1876-0341

DOI - 10.1016/j.jiph.2020.09.009

Subject(s) - lactate dehydrogenase , medicine , lymphocyte , gold standard (test) , covid-19 , gastroenterology , area under the curve , disease , biology , infectious disease (medical specialty) , enzyme , biochemistry

COVID-19 (Coronavirus Disease-2019) is a pandemic disease, infecting more than 26.5 million people. Since there is no specific and effective treatment; early diagnosis and optimal isolation of the patient are of vital importance. Real-time polymerase chain reaction-based (RT-PCR) analyses do not achieve sufficient sensitivity in the diagnosis of the disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research